You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline

You are reading 1 of 2 free-access articles allowed for 30 days

Successful Spring Meeting for ISR

By Mindo - 02nd May 2019 | 11 views

The 2019 Irish Society for Rheumatology (ISR) Spring Meeting called on the Government to fund and implement the new HSE national model of care for rheumatic and musculoskeletal disorders, and increase staffing numbers in the area as a priority.

Speaking to the Medical Independent (MI), ISR President Dr Sinéad Harney, Consultant Rheumatologist at Cork University Hospital, said the model of care provided the blueprint for what needed to be done to provide the services that patients need and deserve.

She described the current situation regarding public rheumatology staffing and the recently-announced temporary recruitment ban as “outrageous”.

“We have over 4,000 patients waiting over 18 months, which is unacceptable, and a more interesting stat is the people waiting three-to-six months which are the more urgent patients and again, that is in the thousands. There is probably a solution if we take rheumatologists off general medicine on-call and let them do just rheumatology; we are not sure if we can achieve that but we will push for it.”

Dr Harney said the Spring Meeting, which took place on 12 April in Dublin, had been very successful and praised the speaker line-up.

“I really enjoyed it. I think it was one of our best spring meetings. Our opening lecture was by Prof Catherine Nelson-Piercy on treating pregnant women, which was very useful. [Prof] Gary MacFarlane spoke about chronic pain and the increased risk of cancer and earlier death in [our patients], which most of us were unaware of. [Prof] Raashid Luqmani was his usual tour de force on vasculitides, and brought over some very interesting points from Oxford, while [Dr] Austin O’Carroll probably gave the most thought-provoking lecture on managing health in the homeless and why we should be doing a better job than we are, which was something slightly different. And the last speaker was [Prof] Andrea Kalus from Washington on dermatology issues so [it was] probably our best programme, balanced-out between men and women, and a variety of disorders that we commonly treat.”

Earlier in the day there was also a consultant advisory group (CAG) meeting. “We talked about the changes in prescribing practice, which was important,” according to Dr Harney.

“It was all about how we interact with the HSE and change and yet again there was substantial discussion about lack of infrastructure and resources. Every unit in the country is particularly poorly-staffed either from nursing, medical, physio, OT or physical infrastructure, with the south-west probably being the worst.”

Regarding the long-awaited national policy on biosimilars, she said the Government needs to finally make decisions on the issues and the naming of preferred biosimilars in rheumatology, adding that they also need to recognise that clinicians will need “nursing staff or allied health professionals to help us sell this to our patients so they don’t perceive them as just cheaper drugs”.

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read